Quest Diagnostics Inc. (DGX)
NYSE · Healthcare
Quest Diagnostics Inc. Shareholder Equity 2007–2025
Quest Diagnostics Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Quest Diagnostics Inc. shareholder equity as of December 31, 2025: 7.17B, a 5.78% increase year-over-year.
- Quest Diagnostics Inc. shareholder equity for 2025 were 7.17B, a 5.78% increase from 2024.
- Quest Diagnostics Inc. shareholder equity for 2024 were 6.78B, a 7.47% increase from 2023.
- Quest Diagnostics Inc. shareholder equity for 2023 were 6.31B, a 7.03% increase from 2022.
- Quest Diagnostics Inc. shareholder equity for 2022 were 5.89B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Quest Diagnostics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7,170 |
| 2024 | $6,778 |
| 2023 | $6,307 |
| 2022 | $5,893 |
| 2021 | $6,444 |
| 2020 | $6,759 |
| 2019 | $5,641 |
| 2018 | $5,216 |
| 2017 | $4,921 |
| 2016 | $4,628 |
| 2015 | $4,684 |
| 2014 | $4,301 |
| 2013 | $3,948 |
| 2012 | $4,163 |
| 2011 | $3,693 |
Quest Diagnostics Inc. Shareholder Equity — FAQ
Quest Diagnostics Inc. (DGX) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DGX's shareholder equity history?
The chart and table above show Quest Diagnostics Inc.'s shareholder equity by year and by quarter, including the growth rate.